Share Based Compensation (Tables)

12 Months Ended

Dec. 31, 2023

2014 Share Incentive Plan

Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]

Schedule of Number, Weighted Average Exercise Prices and Weighted Average Grant Date Fair Value of Share Options

The option holders may elect at any time to exercise any part or all of the vested options before the expiry date.

	Number of			Weighted- average exercise price		Weighted- average grant date fair value
	options			(US$)		(US$)
Outstanding as at January 1, 2021		5,983,900			0.23		1.93
Exercised		(2,992,122	)		0.24		1.92
Outstanding as at December 31, 2021		2,991,778			0.22		1.94
Vested and expected to vest as at December 31, 2021		2,991,778			0.22		1.94
Exercisable as at December 31, 2021		2,991,778			0.22		1.94
Non vested as at December 31, 2021		-			-		-
Outstanding as at January 1, 2022		2,991,778			0.22		1.94
Exercised		(1,579,006	)		0.23		1.94
Outstanding as at December 31, 2022		1,412,772			0.22		1.93
Vested and expected to vest as at December 31, 2022		1,412,772			0.22		1.93
Exercisable as at December 31, 2022		1,412,772			0.22		1.93
Non vested as at December 31, 2022		-			-		-
Outstanding as at January 1, 2023		1,412,772			0.22		1.93
Exercised		(479,788	)		0.25		1.90
Forfeited		(21,920	)		0.27		1.93
Outstanding as at December 31, 2023		911,064			0.20		1.95
Vested and expected to vest as at December 31, 2023		911,064			0.20		1.95
Exercisable as at December 31, 2023		911,064			0.20		1.95
Non vested as at December 31, 2023		-			-		-

Schedule of Share Options Outstanding

Share options outstanding at the end of the year have the following expiry date and exercise prices:

			As at December 31,
Expiry date	Exercise price		2022		2023
10 years commencing from the date of grant of options		US$0.000076		256,210		219,210
		US$0.27		1,156,562		691,854
Total				1,412,772		911,064
Weighted average remaining contractual life of    options outstanding at end of year:			2.91			1.88

2017 Restricted Share Scheme and 2017 Option Plan

Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]

Summary of Assumptions Used to Determine Fair value of Share Options

Assumptions used in the Binomial option-pricing model are presented below:

	Year ended December 31,
	2021	2022	2023
Risk free interest rate	1.22%-1.63%	2.15%-2.92%	3.46%-3.83%
Expected dividend yield	0%	0%	0%
Expected volatility	43.5%-50%	55%-60%	60%
Exercise multiples	2.2-2.8	2.2-2.8	2.2-2.8
Contractual life	10 years	10 years	10 years

Schedule of Number, Weighted Average Exercise Prices and Weighted Average Grant Date Fair Value of Share Options

	Number of options			Weighted- average exercise price (US$)		Weighted- average grant date fair value (US$)
Outstanding as at January 1, 2021		21,151,186			4.45		2.68
Granted		8,543,982			5.54		2.81
Exercised		(4,360,740	)		1.92		2.26
Forfeited		(541,488	)		5.70		2.90
Outstanding as at December 31, 2021		24,792,940			5.24		2.79
Vested and expected to vest as at December 31, 2021		23,552,634			5.21		2.79
Exercisable as at December 31, 2021		9,580,612			4.00		2.64
Non vested as at December 31, 2021		15,212,328			6.03		2.88
Outstanding as at January 1, 2022		24,792,940			5.24		2.79
Granted		24,957,454			2.05		1.02
Exercised		(566,612	)		0.68		2.67
Forfeited		(1,079,240	)		4.78		2.25
Outstanding as at December 31, 2022		48,104,542			3.65		1.89
Vested and expected to vest as at December 31, 2022		45,601,007			3.68		1.91
Exercisable as at December 31, 2022		14,272,122			4.93		2.75
Non vested as at December 31, 2022		33,832,420			3.11		1.52
Outstanding as at January 1, 2023		48,104,542			3.65		1.89
Granted		1,958,914			3.81		2.18
Exercised		(3,851,238	)		2.16		1.42
Forfeited		(2,398,792	)		4.49		2.15
Outstanding as at December 31, 2023		43,813,426			3.74		1.93
Vested and expected to vest as at December 31, 2023		42,189,736			3.77		1.94
Exercisable as at December 31, 2023		21,062,538			4.65		2.42
Non vested as at December 31, 2023		22,750,888			2.90		1.47

Schedule of Share Options Outstanding

Share options outstanding at the end of the year have the following expiry date and exercise prices:

Expiry date	Exercise price		December 31,		December 31,
			2022		2023
10 years commencing from the date of grant of options		US$0.27		818,024		539,620
		US$1.93		15,952,792		14,213,356
	US$2.24~US$2.32			12,871,384		10,527,104
		US$3.32		307,792		2,011,512
	US$4.04 ~ US$4.24			579,952		254,952
		US$5.29		5,803,160		5,283,344
	US$6.20 ~ US$6.37			4,015,280		3,767,380
	US$7.05 ~ US$7.61			7,587,078		7,047,078
		US$9.53		169,080		169,080
Total				48,104,542		43,813,426
Weighted average remaining contractual life of options outstanding at end of year:				8.12		7.22

Schedule of Movements in Number of RSUs and Awarded Shares

Movements in the number of RSUs for the years ended December 31, 2021, 2022 and 2023 are as follows:

	Number of awarded shares
	Year ended December 31,
	2021			2022			2023
Outstanding as at January 1		41,011,362			43,728,098			59,463,350
Granted		19,136,384			35,601,446			20,502,878
Vested		(13,096,270	)		(14,787,382	)		(23,885,214	)
Forfeited		(3,323,378	)		(5,078,812	)		(5,355,522	)
Outstanding as at December 31		43,728,098			59,463,350			50,725,492
Expected to vest as at December 31		39,425,569			53,009,743			45,097,852